256 related articles for article (PubMed ID: 30367606)
1. Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma.
Park J; Jung J; Kim D; Jung IH; Park JH; Kim JH; Lee SW; Yoon SM
BMC Cancer; 2018 Oct; 18(1):1040. PubMed ID: 30367606
[TBL] [Abstract][Full Text] [Related]
2. Two-week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma.
Park JH; Yoon SM; Lim YS; Kim SY; Shim JH; Kim KM; Lee HC; Cho B; Park G; Kim JH
J Gastroenterol Hepatol; 2013 Oct; 28(10):1638-42. PubMed ID: 23621519
[TBL] [Abstract][Full Text] [Related]
3. Salvage treatment with hypofractionated radiotherapy in patients with recurrent small hepatocellular carcinoma.
Bae SH; Park HC; Lim DH; Lee JA; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e603-7. PubMed ID: 22208963
[TBL] [Abstract][Full Text] [Related]
4. High dose radiotherapy with image-guided hypo-IMRT for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombi is more feasible and efficacious than conventional 3D-CRT.
Hou JZ; Zeng ZC; Wang BL; Yang P; Zhang JY; Mo HF
Jpn J Clin Oncol; 2016 Apr; 46(4):357-62. PubMed ID: 26802166
[TBL] [Abstract][Full Text] [Related]
5. Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?
Yu JI; Park HC; Lim DH; Paik SW
Cancer Res Treat; 2016 Apr; 48(2):574-82. PubMed ID: 26194367
[TBL] [Abstract][Full Text] [Related]
6. Local control by salvage stereotactic body radiotherapy for recurrent/residual hepatocellular carcinoma after other local therapies.
Kibe Y; Takeda A; Tsurugai Y; Eriguchi T
Acta Oncol; 2020 Aug; 59(8):888-894. PubMed ID: 32216593
[No Abstract] [Full Text] [Related]
7. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
Sanuki N; Takeda A; Oku Y; Mizuno T; Aoki Y; Eriguchi T; Iwabuchi S; Kunieda E
Acta Oncol; 2014 Mar; 53(3):399-404. PubMed ID: 23962244
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
Wu DH; Chen LH
Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma.
Shiba S; Shibuya K; Okamoto M; Okazaki S; Komatsu S; Kubota Y; Nakano T; Ohno T
Radiat Oncol; 2020 Aug; 15(1):195. PubMed ID: 32795340
[TBL] [Abstract][Full Text] [Related]
11. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalities.
Lim DH; Lee H; Park HC; Lee JA; Kim SW; Yoo BC; Koh KC; Lee JH; Choi MS; Gwak GY; Paik SW
Am J Clin Oncol; 2013 Apr; 36(2):162-6. PubMed ID: 22391433
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated radiotherapy as a salvage treatment for recurrent hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: a multi-center analysis.
Lou J; Li Y; Liang K; Guo Y; Song C; Chen L; Wang L; Wang F; Zhang L; Chen X; Xu X; Pan M
BMC Cancer; 2019 Jul; 19(1):668. PubMed ID: 31277593
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome and toxicity of radiotherapy for inferior vena cava tumor thrombus in HCC patients: A retrospective study.
Lee SJ; Jang HS; Choi YK
Medicine (Baltimore); 2021 Jun; 100(25):e26390. PubMed ID: 34160420
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma.
Yoon SM; Lim YS; Park MJ; Kim SY; Cho B; Shim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Lee YS; Park JH; Kim JH
PLoS One; 2013; 8(11):e79854. PubMed ID: 24255719
[TBL] [Abstract][Full Text] [Related]
16. A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger.
Shibuya K; Ohno T; Katoh H; Okamoto M; Shiba S; Koyama Y; Kakizaki S; Shirabe K; Nakano T
Radiother Oncol; 2019 Mar; 132():230-235. PubMed ID: 30366726
[TBL] [Abstract][Full Text] [Related]
17. Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma.
Kim JW; Seong J; Lee IJ; Woo JY; Han KH
Oncotarget; 2016 Jun; 7(26):40756-40766. PubMed ID: 27213593
[TBL] [Abstract][Full Text] [Related]
18. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
[TBL] [Abstract][Full Text] [Related]
19. Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy.
Lasley FD; Mannina EM; Johnson CS; Perkins SM; Althouse S; Maluccio M; Kwo P; Cárdenes H
Pract Radiat Oncol; 2015; 5(5):e443-e449. PubMed ID: 25899219
[TBL] [Abstract][Full Text] [Related]
20. The comparison of outcomes between hypofractionated and conventional 3D-CRT regimens used in combination with TACE as first-line treatment of advanced hepatocellular carcinoma.
Wang C; Li S; Sun A; Chen L; Liang R; Li G; Han J
Tumour Biol; 2015 Jul; 36(7):4967-72. PubMed ID: 25773387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
